Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Alexei Kharitonenkov, Armen B Shanafelt

Abstract

Fibroblast growth factor (FGF)-21 is a unique member of the FGF family, with several molecular characteristics that differ from classical FGFs and exhibiting a pharmacologic profile that includes a variety of metabolic responses in vitro and when tested in vivo in animal models. FGF21 represents a novel and attractive therapeutic agent for type 2 diabetes mellitus, because of its ability to modulate disease phenotype in preclinical settings without inducing any apparent adverse effects. Although FGF21 was discovered relatively recently, the understanding of its biology and therapeutic utility is rapidly evolving. A number of key metabolically linked molecules and pathways have been suggested to be involved in the mechanism of action of FGF21, depending on the specific target tissue/organ. Further research into these mechanisms should lead to important advances in the understanding of FGF21 biology and pave the way for novel therapeutic strategies. The specifics of FGF21 activities both in cell culture and in vivo, its potential as a target for diabetes, and insights into the molecular mechanisms of FGF21 metabolic actions will be discussed in this review.

References

Oct 8, 2005·Omics : a Journal of Integrative Biology·Keith BoyceJohn J Kopchick

❮ Previous
Next ❯

Citations

May 30, 2012·Nature Reviews. Endocrinology·M Shawkat Razzaque
Mar 25, 2010·The Journal of Biological Chemistry·Yongjun WangThomas P Burris
Jul 24, 2010·The Journal of Biological Chemistry·Chad CsepeggiAndrey Frolov
Jul 27, 2010·Human Molecular Genetics·Henna TyynismaaAnu Suomalainen
Jul 29, 2010·American Journal of Physiology. Endocrinology and Metabolism·Eric D BerglundDavid H Wasserman
Nov 26, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bing ZhuTroy Stevens
Feb 19, 2011·Journal of Nutrition and Metabolism·Yusuke MurataNobuyuki Itoh
May 2, 2012·The Journal of Clinical Investigation·Fadila BenhamedCatherine Postic
Jun 8, 2012·PloS One·Andrew C AdamsAlexei Kharitonenkov
Apr 22, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mingming GaoDexi Liu
Mar 12, 2009·Cellular and Molecular Life Sciences : CMLS·Mikael Rydén
Oct 25, 2008·FEBS Letters·Yasuhiro IzumiyaKenneth Walsh
Aug 8, 2009·FEBS Letters·Katsumi IizukaYukio Horikawa
Jan 23, 2016·PeerJ·Quentin M NunesDavid G Fernig
Dec 6, 2011·Metabolism: Clinical and Experimental·Wei-Xia JianQing Su
May 11, 2010·Diabetes Research and Clinical Practice·Kazuhiro EtoShun Ishibashi
Aug 25, 2009·Metabolism: Clinical and Experimental·Sebastian SteinMathias Fasshauer
Jan 1, 2009·Journal of Cellular Physiology·Radmila MicanovicAlexei Kharitonenkov
Oct 7, 2010·Journal of Diabetes·Yifei ZhangZachary T Bloomgarden
Feb 11, 2011·Diabetes/metabolism Research and Reviews·Fredirick L MashiliAnna Krook
Apr 1, 2016·Medicinal Research Reviews·Wing Yan So, Po Sing Leung
Apr 7, 2010·Metabolism: Clinical and Experimental·Knut MaiJoachim Spranger
Apr 21, 2011·Biochimica Et Biophysica Acta·Yun Chau Long, Alexei Kharitonenkov
Dec 24, 2014·Bioanalysis·Tara S UmbergerRobert J Konrad
Sep 2, 2009·Diabetes·Pernille HojmanBente Klarlund Pedersen
Jul 16, 2009·Diabetes·Alessandro PocaiRanabir SinhaRoy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.